Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Jun:75:103703.
doi: 10.1016/j.breast.2024.103703. Epub 2024 Mar 5.

Accuracy of sentinel lymph node biopsy in male breast cancer: Systematic review and meta-analysis

Affiliations
Meta-Analysis

Accuracy of sentinel lymph node biopsy in male breast cancer: Systematic review and meta-analysis

Guillaume Parpex et al. Breast. 2024 Jun.

Abstract

Background: Sentinel lymph node biopsy (SLNB) is commonly used in the surgical management of male breast cancer. Contrary to female breast cancer, limited data exist about its performance in male breast cancer. The objective of this systematic review and meta-analysis was to evaluate the SLNB accuracy in male breast cancer.

Methods: MEDLINE, EMBASE, Web of Science and The Cochrane Library were searched from January 1995 to April 2023 for studies evaluating the SLNB identification rate and false-negative rate in male breast cancer with negative preoperative axillary evaluation and primary surgery. For SLNB false-negative rate, the gold standard was the histology of axillary lymph node dissection (ALDN). Methodological quality was assessed by using the QUADAS-2 tool. Pooled estimates of the SLNB identification rate and false-negative rate were calculated. Heterogeneity of the pooled studies was evaluated using I2 index.

Results: A total of 12 retrospective studies were included. The 12 studies that reported the SLNB identification rate gathered a total of 164 patients; the 5 studies that reported the SLNB false-negative rate gathered a total of 50 patients with a systematic ALND. The pooled estimate of the SLNB identification rate was 99.0%. The SLNB false-negative rates were 0% in the 5 included studies and consequently so as the pooled estimate of the false-negative rate with no heterogeneity.

Conclusion: SLNB for male breast cancer, following negative preoperative axillary assessment and primary surgery, appears feasible, consistent, and effective. Our research supports conducting immediate SLNB histological evaluation to facilitate prompt ALND in case of positive results.

Keywords: Accuracy; False-negative rate; Identification rate; Male breast cancer; Meta-analysis; Sentinel lymph node biopsy; Systematic review.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
PRISMA flow chart of the study selection process.
Fig. 2
Fig. 2
QUADAS-2 risk of bias and applicability concerns.
Fig. 3
Fig. 3
Forest plot of the SLNB identification rate. Identification rates are reported with 95% confidence intervals. The pooled estimate rate was 99.0% (95% CI 97.1%–101.0%). The heterogeneity score (I2) was 0.00% (p = 0.85).

Similar articles

Cited by

References

    1. Mj H., Mr S., Er B., F C., Kj K., Dc K., et al. Management of male breast cancer: ASCO guideline. J Clin Oncol : Official Journal of the American Society of Clinical Oncology. 2020;38 doi: 10.1200/JCO.19.03120. - DOI - PubMed
    1. Siegel R.L., Miller K.D., Fuchs H.E., Jemal A. Cancer statistics. CA Cancer J Clin. 2022;72:7–33. doi: 10.3322/caac.21708. 2022. - DOI - PubMed
    1. Cancer Statistics Review, 1975-2015 - Previous Version - SEER Cancer Statistics Review.SEER n.d. https://seer.cancer.gov/archive/csr/1975_2015/index.html (accessed January 31, 2022).
    1. Borgen P.I., Wong G.Y., Vlamis V., Potter C., Hoffmann B., Kinne D.W., et al. Current management of male breast cancer. A review of 104 cases. Ann Surg. 1992;215:451–457. doi: 10.1097/00000658-199205000-00007. ; discussion 457-459. - DOI - PMC - PubMed
    1. Veronesi U., Paganelli G., Galimberti V., Viale G., Zurrida S., Bedoni M., et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997;349:1864–1867. doi: 10.1016/S0140-6736(97)01004-0. - DOI - PubMed